UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF JUNE 2021


COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes  No 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes  No 

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

GENMAB A/S

BY:

/s/ Anthony Pagano

Name: Anthony Pagano

Title: Executive Vice President & Chief Financial Officer

DATE: June 1, 2021


EXHIBIT INDEX

O

Exhibit

Description of Exhibit

99.1

Company Announcement Dated May 31, 2021: Transactions in connection with share buy-back program

99.1(a)

Appendix: Transactions May 25-28, 2021


Exhibit 99.1

Graphic

Transactions in connection with share buy-back program

Company Announcement

COPENHAGEN, Denmark; May 31, 2021 – Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares.

The following transactions were executed under the program from May 24, 2021 to May 28, 2021:

 

No. of shares

Average price (DKK)

Total value (DKK)

Accumulated through last announcement

147,800

 

312,016,533

May 24, 2021

0

N/A

0

May 25, 2021

1,800

2,437.38

4,387,284

May 26, 2021

May 27, 2021

1,700

1,900

2,437.76

2,422.26

4,144,192

4,602,294

May 28, 2021

1,800

2,469.66

4,445,388

Total

7,200

17,579,158

Accumulated under the program

155,000

 

329,595,691

Details of each transaction are included as an appendix to this announcement.

Following these transactions, Genmab holds 254,206 shares as treasury shares, corresponding to 0.39% of the total share capital and voting rights.

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 11 dated February 23, 2021.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 47

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 1/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Graphic

Transactions in connection with share buy-back program

Contact:
Marisol Peron, Senior Vice President, Global Investor Relations & Communications

T: +1 609 524 0065; E: mmp@genmab.com

For Investor Relations:

Andrew Carlsen, Vice President, Head of Investor Relations

T: +45 3377 9558; E: acn@genmab.com


This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.


Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody® and HexElect®.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 47

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 2/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

Volume

Price

Venue

Time CET

20

2503

XCSE

20210528 16:07:38.613000

18

2503

XCSE

20210528 16:07:38.613000

9

2501

XCSE

20210528 16:03:06.402000

10

2501

XCSE

20210528 16:03:08.058000

19

2499

XCSE

20210528 16:04:04.344000

18

2499

XCSE

20210528 16:15:17.877000

19

2499

XCSE

20210528 16:15:17.877000

18

2498

XCSE

20210528 16:11:23.998000

20

2498

XCSE

20210528 16:11:23.998000

9

2498

XCSE

20210528 16:44:23.596000

15

2498

XCSE

20210528 16:44:23.596000

20

2498

XCSE

20210528 16:44:25.882000

18

2498

XCSE

20210528 16:44:27.538000

23

2497

XCSE

20210528 16:36:23.339000

3

2497

XCSE

20210528 16:44:33.849000

16

2496

XCSE

20210528 15:59:55.866000

2

2496

XCSE

20210528 15:59:55.866000

19

2496

XCSE

20210528 16:23:36.778000

18

2496

XCSE

20210528 16:27:58.321000

10

2493

XCSE

20210528 16:21:40.904000

9

2493

XCSE

20210528 16:21:40.904000

17

2492

XCSE

20210528 15:53:16.100000

1

2492

XCSE

20210528 15:53:16.100000

20

2492

XCSE

20210528 15:58:08.839000

19

2491

XCSE

20210528 15:51:55.262000

23

2488

XCSE

20210528 15:49:03.145000

19

2488

XCSE

20210528 15:49:03.145000

4

2488

XCSE

20210528 15:49:03.145000

19

2488

XCSE

20210528 15:56:10.201000

19

2485

XCSE

20210528 15:40:28.961000

19

2485

XCSE

20210528 15:43:03.089000

20

2483

XCSE

20210528 15:38:03.062000

18

2483

XCSE

20210528 15:44:14.179000

18

2478

XCSE

20210528 15:33:08.409000

18

2477

XCSE

20210528 15:31:42.243000

19

2475

XCSE

20210528 15:06:36.557000

18

2475

XCSE

20210528 15:35:50.292000

28

2473

XCSE

20210528 15:25:54.560000

1


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

34

2473

XCSE

20210528 15:25:54.560000

21

2473

XCSE

20210528 15:25:54.560000

20

2472

XCSE

20210528 15:18:47.944000

18

2472

XCSE

20210528 15:26:58.570000

31

2472

XCSE

20210528 15:26:58.570000

6

2472

XCSE

20210528 15:26:58.570000

18

2471

XCSE

20210528 15:14:50.080000

18

2471

XCSE

20210528 15:14:50.080000

19

2471

XCSE

20210528 15:29:59.126000

19

2471

XCSE

20210528 15:29:59.126000

18

2469

XCSE

20210528 15:05:22.022000

20

2467

XCSE

20210528 14:55:05.669000

18

2466

XCSE

20210528 15:03:04.797000

18

2466

XCSE

20210528 15:03:04.797000

18

2465

XCSE

20210528 11:58:59.786000

18

2464

XCSE

20210528 11:42:32.476000

7

2463

XCSE

20210528 12:21:48.103000

12

2463

XCSE

20210528 12:21:48.103000

18

2462

XCSE

20210528 10:18:07.158000

22

2462

XCSE

20210528 11:11:25.488000

18

2462

XCSE

20210528 12:36:36.805000

18

2462

XCSE

20210528 14:46:07.282000

18

2461

XCSE

20210528 10:51:52.046000

18

2461

XCSE

20210528 11:00:42.292000

21

2461

XCSE

20210528 11:23:20.954000

18

2461

XCSE

20210528 12:43:24.534000

21

2461

XCSE

20210528 13:10:26.447000

18

2461

XCSE

20210528 13:28:08.651000

18

2461

XCSE

20210528 13:38:11.706000

1

2461

XCSE

20210528 13:38:11.742000

11

2461

XCSE

20210528 14:35:20.279000

9

2461

XCSE

20210528 14:35:20.279000

32

2461

XCSE

20210528 14:40:58.575000

18

2460

XCSE

20210528 10:32:03.409000

25

2460

XCSE

20210528 10:42:53.829000

14

2460

XCSE

20210528 13:56:46.176000

4

2460

XCSE

20210528 13:56:46.176000

18

2460

XCSE

20210528 14:22:32.976000

23

2460

XCSE

20210528 14:22:32.976000

2


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

15

2459

XCSE

20210528 11:34:25.999000

21

2459

XCSE

20210528 13:35:16.356000

18

2459

XCSE

20210528 13:47:00.392000

21

2459

XCSE

20210528 13:57:25.950000

1

2459

XCSE

20210528 14:07:43.262000

5

2459

XCSE

20210528 14:07:47.116000

12

2459

XCSE

20210528 14:07:58.520000

18

2459

XCSE

20210528 14:30:02.786000

18

2459

XCSE

20210528 14:30:02.786000

18

2458

XCSE

20210528 10:25:14.989000

18

2458

XCSE

20210528 12:10:09.044000

18

2458

XCSE

20210528 12:59:14.791000

23

2454

XCSE

20210528 10:04:36.190000

22

2453

XCSE

20210528 9:44:10.298000

21

2452

XCSE

20210528 9:51:37.118000

21

2451

XCSE

20210528 9:37:36.086000

18

2450

XCSE

20210528 9:57:22.866000

19

2449

XCSE

20210528 10:11:50.439000

1

2448

XCSE

20210528 9:23:50.291000

21

2448

XCSE

20210528 9:23:50.291000

15

2445

XCSE

20210528 9:34:09.692000

20

2444

XCSE

20210528 9:17:14.577000

19

2444

XCSE

20210528 9:28:05.288000

22

2439

XCSE

20210528 9:10:00.264000

20

2439

XCSE

20210528 9:12:50.632000

22

2436

XCSE

20210528 9:00:14.875000

27

2434

XCSE

20210528 9:06:40.579000

9

2428

XCSE

20210528 9:02:35.084000

9

2428

XCSE

20210528 9:02:35.084000

19

2432

XCSE

20210527 9:00:09.646000

18

2435

XCSE

20210527 9:03:14.673000

10

2433

XCSE

20210527 9:06:27.653000

9

2433

XCSE

20210527 9:06:27.653000

18

2429

XCSE

20210527 9:09:58.844000

19

2432

XCSE

20210527 9:14:34.657000

19

2435

XCSE

20210527 9:17:57.124000

18

2431

XCSE

20210527 9:22:42.862000

18

2430

XCSE

20210527 9:28:16.795000

20

2430

XCSE

20210527 9:34:54.796000

3


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

19

2430

XCSE

20210527 9:42:26.728000

18

2430

XCSE

20210527 9:48:20.780000

19

2429

XCSE

20210527 9:56:21.391000

15

2433

XCSE

20210527 10:03:42.825000

3

2433

XCSE

20210527 10:03:42.825000

19

2430

XCSE

20210527 10:13:32.330000

2

2417

XCSE

20210527 10:20:47.698000

19

2418

XCSE

20210527 10:22:00.556000

19

2417

XCSE

20210527 10:30:48.607000

18

2418

XCSE

20210527 10:42:14.486000

20

2420

XCSE

20210527 10:51:51.139000

19

2424

XCSE

20210527 11:03:49.589000

24

2425

XCSE

20210527 11:17:42.379000

21

2419

XCSE

20210527 11:33:02.689000

18

2419

XCSE

20210527 11:37:54.258000

18

2412

XCSE

20210527 11:56:00.802000

18

2411

XCSE

20210527 12:17:21.942000

18

2416

XCSE

20210527 12:34:58.085000

18

2421

XCSE

20210527 12:49:07.690000

18

2423

XCSE

20210527 13:06:18.249000

18

2418

XCSE

20210527 13:22:18.282000

18

2420

XCSE

20210527 13:38:00.336000

18

2420

XCSE

20210527 13:55:00.596000

18

2423

XCSE

20210527 14:08:47.942000

20

2422

XCSE

20210527 14:24:11.855000

18

2417

XCSE

20210527 14:38:00.337000

20

2412

XCSE

20210527 14:42:41.199660

20

2412

XCSE

20210527 14:42:41.199716

20

2412

XCSE

20210527 14:42:41.199719

20

2412

XCSE

20210527 14:42:54.168152

20

2412

XCSE

20210527 14:42:54.168231

18

2412

XCSE

20210527 14:53:13.290000

21

2411

XCSE

20210527 15:18:38.502000

25

2411

XCSE

20210527 15:19:36.547000

19

2412

XCSE

20210527 15:24:55.211000

24

2415

XCSE

20210527 15:29:54.765000

18

2417

XCSE

20210527 15:35:40.252000

18

2419

XCSE

20210527 15:42:53.570000

19

2415

XCSE

20210527 15:49:20.855000

4


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

19

2404

XCSE

20210527 15:56:14.785000

19

2409

XCSE

20210527 16:04:41.264000

2

2412

XCSE

20210527 16:14:06.201000

28

2412

XCSE

20210527 16:14:06.201000

19

2413

XCSE

20210527 16:23:49.611000

18

2421

XCSE

20210527 16:39:29.901000

3

2423

XCSE

20210527 16:44:18.283000

9

2423

XCSE

20210527 16:44:18.283000

25

2424

XCSE

20210527 16:49:44.695914

225

2424

XCSE

20210527 16:49:44.695914

630

2425

XCSE

20210527 16:53:13.725010

20

2425

XCSE

20210527 16:53:13.725010

19

2449

XCSE

20210526 9:03:24.037000

25

2449

XCSE

20210526 9:32:06.893000

20

2448

XCSE

20210526 9:08:58.487000

14

2448

XCSE

20210526 9:09:23.381000

19

2448

XCSE

20210526 9:36:42.971000

19

2447

XCSE

20210526 9:05:10.679000

19

2447

XCSE

20210526 9:10:12.721000

13

2447

XCSE

20210526 9:17:49.331000

8

2447

XCSE

20210526 9:17:49.331000

18

2447

XCSE

20210526 9:26:31.213000

20

2446

XCSE

20210526 9:23:04.478000

22

2446

XCSE

20210526 15:34:54.923000

21

2446

XCSE

20210526 15:35:30.743000

19

2445

XCSE

20210526 9:12:45.431000

9

2445

XCSE

20210526 9:42:43.267000

9

2445

XCSE

20210526 9:43:01.828000

29

2443

XCSE

20210526 9:01:44.584000

19

2443

XCSE

20210526 15:22:27.815000

27

2443

XCSE

20210526 15:41:16.748000

12

2443

XCSE

20210526 15:43:36.015000

8

2443

XCSE

20210526 15:43:36.015000

19

2443

XCSE

20210526 15:47:08.064000

18

2442

XCSE

20210526 9:14:47.777000

18

2442

XCSE

20210526 15:02:09.479000

28

2442

XCSE

20210526 15:52:25.508000

24

2442

XCSE

20210526 16:14:14.684000

25

2441

XCSE

20210526 15:24:28.891000

5


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

26

2441

XCSE

20210526 15:55:54.179000

16

2441

XCSE

20210526 16:10:02.231000

19

2441

XCSE

20210526 16:10:02.231000

13

2441

XCSE

20210526 16:10:02.231000

19

2440

XCSE

20210526 15:28:02.091000

55

2440

XCSE

20210526 16:33:57.157393

18

2439

XCSE

20210526 9:46:05.040000

18

2439

XCSE

20210526 9:49:18.436000

6

2439

XCSE

20210526 10:20:03.460000

14

2439

XCSE

20210526 10:20:03.460000

10

2439

XCSE

20210526 10:20:03.460000

19

2439

XCSE

20210526 15:09:35.346000

50

2439

XCSE

20210526 15:19:54.154000

12

2439

XCSE

20210526 15:19:54.154000

20

2439

XCSE

20210526 15:28:38.895000

23

2438

XCSE

20210526 9:57:15.079000

33

2438

XCSE

20210526 10:10:03.367000

18

2438

XCSE

20210526 16:21:54.015000

12

2437

XCSE

20210526 10:27:41.462000

7

2437

XCSE

20210526 10:27:41.462000

18

2437

XCSE

20210526 12:55:49.621000

27

2437

XCSE

20210526 14:29:39.558000

20

2437

XCSE

20210526 14:45:48.639000

1

2437

XCSE

20210526 14:45:50.397000

18

2437

XCSE

20210526 14:53:02.310000

15

2436

XCSE

20210526 10:03:49.055000

4

2436

XCSE

20210526 10:03:49.072000

13

2436

XCSE

20210526 14:44:53.790000

18

2436

XCSE

20210526 16:26:01.246000

22

2435

XCSE

20210526 12:42:53.671000

18

2435

XCSE

20210526 13:05:58.743000

23

2435

XCSE

20210526 13:14:48.996000

18

2435

XCSE

20210526 14:32:49.257000

19

2434

XCSE

20210526 9:00:03.583000

19

2434

XCSE

20210526 10:29:45.083000

18

2434

XCSE

20210526 12:50:29.853000

18

2434

XCSE

20210526 13:23:40.009000

31

2434

XCSE

20210526 14:08:06.376000

7

2434

XCSE

20210526 14:08:06.376000

6


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

19

2434

XCSE

20210526 15:59:29.174000

18

2434

XCSE

20210526 16:03:01.080000

5

2433

XCSE

20210526 10:52:55.200000

8

2433

XCSE

20210526 10:52:55.200000

5

2433

XCSE

20210526 10:52:55.200000

11

2433

XCSE

20210526 10:59:28.034000

10

2433

XCSE

20210526 10:59:28.034000

5

2433

XCSE

20210526 11:10:24.175000

7

2433

XCSE

20210526 11:10:32.900000

12

2433

XCSE

20210526 11:12:41.810000

22

2433

XCSE

20210526 11:17:36.338000

28

2433

XCSE

20210526 14:20:08.014000

13

2432

XCSE

20210526 11:00:53.497000

25

2431

XCSE

20210526 11:46:57.357000

19

2431

XCSE

20210526 12:32:55.761000

22

2430

XCSE

20210526 10:41:19.758000

10

2430

XCSE

20210526 11:25:23.114000

8

2430

XCSE

20210526 11:25:30.869000

20

2430

XCSE

20210526 12:07:17.045000

34

2429

XCSE

20210526 10:34:25.979000

18

2429

XCSE

20210526 11:34:18.872000

18

2429

XCSE

20210526 11:37:33.779000

18

2429

XCSE

20210526 11:56:30.823000

18

2429

XCSE

20210526 12:22:44.959000

12

2428

XCSE

20210526 13:28:21.004000

6

2428

XCSE

20210526 13:28:21.004000

18

2428

XCSE

20210526 13:46:10.603000

19

2427

XCSE

20210526 12:17:10.657000

18

2427

XCSE

20210526 13:53:31.517000

18

2426

XCSE

20210526 13:37:11.560000

21

2430

XCSE

20210525 9:14:08.878000

21

2440

XCSE

20210525 9:17:34.353000

10

2437

XCSE

20210525 9:22:43.826000

11

2437

XCSE

20210525 9:22:43.847000

22

2444

XCSE

20210525 9:26:10.284000

18

2446

XCSE

20210525 9:30:13.612000

18

2443

XCSE

20210525 9:35:04.586000

19

2440

XCSE

20210525 9:39:55.681000

18

2445

XCSE

20210525 9:44:43.349000

7


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

21

2437

XCSE

20210525 9:50:15.161000

25

2433

XCSE

20210525 9:57:09.344000

23

2431

XCSE

20210525 10:02:46.059000

25

2428

XCSE

20210525 10:10:16.129000

18

2427

XCSE

20210525 10:14:21.773000

21

2437

XCSE

20210525 10:28:35.795000

25

2437

XCSE

20210525 10:28:35.795000

28

2436

XCSE

20210525 10:37:03.301000

18

2433

XCSE

20210525 10:42:58.019000

23

2434

XCSE

20210525 10:51:49.872000

18

2434

XCSE

20210525 10:59:05.014000

25

2440

XCSE

20210525 11:09:00.094000

18

2445

XCSE

20210525 11:16:13.051000

19

2440

XCSE

20210525 11:23:57.932000

23

2443

XCSE

20210525 11:35:46.576000

19

2440

XCSE

20210525 11:42:32.813000

18

2439

XCSE

20210525 11:51:46.123000

18

2435

XCSE

20210525 12:06:03.035000

18

2430

XCSE

20210525 12:11:40.134000

18

2426

XCSE

20210525 12:23:39.281000

20

2429

XCSE

20210525 12:30:32.620000

18

2430

XCSE

20210525 12:38:39.692000

20

2432

XCSE

20210525 12:48:24.736000

18

2433

XCSE

20210525 12:55:09.602000

18

2433

XCSE

20210525 13:04:48.229000

18

2438

XCSE

20210525 13:14:19.122000

21

2438

XCSE

20210525 13:22:31.983000

1

2441

XCSE

20210525 13:31:05.691000

23

2441

XCSE

20210525 13:34:30.068000

18

2445

XCSE

20210525 13:43:35.055000

18

2447

XCSE

20210525 13:50:58.009000

18

2445

XCSE

20210525 13:52:39.546000

19

2444

XCSE

20210525 14:06:35.117000

19

2448

XCSE

20210525 14:08:23.919000

1

2449

XCSE

20210525 14:15:01.428000

17

2449

XCSE

20210525 14:15:01.429000

18

2448

XCSE

20210525 14:15:50.889000

18

2447

XCSE

20210525 14:21:39.803000

18

2447

XCSE

20210525 14:29:01.641000

8


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

18

2448

XCSE

20210525 14:31:29.726000

18

2448

XCSE

20210525 14:36:15.677000

18

2446

XCSE

20210525 14:45:59.525000

18

2446

XCSE

20210525 14:51:24.171000

18

2445

XCSE

20210525 14:53:23.788000

20

2446

XCSE

20210525 15:03:09.964000

22

2447

XCSE

20210525 15:15:38.028000

36

2447

XCSE

20210525 15:15:38.028000

14

2447

XCSE

20210525 15:18:20.437000

5

2447

XCSE

20210525 15:18:20.437000

19

2445

XCSE

20210525 15:20:11.766000

18

2446

XCSE

20210525 15:23:56.499000

19

2446

XCSE

20210525 15:23:56.499000

8

2443

XCSE

20210525 15:28:00.221000

13

2443

XCSE

20210525 15:28:00.221000

21

2443

XCSE

20210525 15:28:26.401000

19

2442

XCSE

20210525 15:30:48.780000

18

2442

XCSE

20210525 15:30:48.780000

18

2447

XCSE

20210525 15:34:55.477000

18

2440

XCSE

20210525 15:37:55.409000

18

2439

XCSE

20210525 15:37:57.870000

28

2437

XCSE

20210525 15:42:56.973000

36

2436

XCSE

20210525 15:45:32.365000

24

2436

XCSE

20210525 15:45:32.365000

18

2432

XCSE

20210525 15:47:57.720000

19

2426

XCSE

20210525 15:51:37.151000

18

2426

XCSE

20210525 15:51:37.151000

13

2432

XCSE

20210525 15:56:32.864000

17

2432

XCSE

20210525 15:56:32.864000

32

2432

XCSE

20210525 15:56:32.864000

18

2430

XCSE

20210525 16:01:32.026000

19

2430

XCSE

20210525 16:01:32.026000

21

2431

XCSE

20210525 16:03:45.982000

18

2430

XCSE

20210525 16:04:48.092000

18

2429

XCSE

20210525 16:09:07.830000

41

2430

XCSE

20210525 16:11:36.069000

17

2432

XCSE

20210525 16:14:51.542000

24

2432

XCSE

20210525 16:14:51.542000

1

2432

XCSE

20210525 16:14:51.542000

9


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 25-28, 2021

Graphic

18

2428

XCSE

20210525 16:21:04.613000

22

2431

XCSE

20210525 16:26:14.330000

1

2427

XCSE

20210525 16:28:01.386000

17

2427

XCSE

20210525 16:28:01.386000

20

2428

XCSE

20210525 16:38:56.147000

21

2428

XCSE

20210525 16:38:56.147000

43

2426

XCSE

20210525 16:41:56.691647

10